Fairchem Organics Q4 Results: Earnings Call Recording Released for Investor Review

1 min read     Updated on 28 Jul 2026, 06:55 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Fairchem Organics Limited submitted the audio recording of its Q4FY26 earnings call held on July 28, 2026, to NSE and BSE. The call discussed unaudited financial results for the quarter ended June 30, 2026. The recording is accessible via the company's website as per SEBI LODR regulations.

powered bylight_fuzz_icon
46790711

*this image is generated using AI for illustrative purposes only.

Fairchem Organics has submitted the audio recording of its earnings call held on July 28, 2026, to the National Stock Exchange of India Limited and BSE Limited. The call, which began at 4:00 p.m., covered the company's unaudited financial results for the quarter ended June 30, 2026 (Q4FY26). This submission ensures transparency and allows investors and analysts to review management's commentary on the latest financial performance.

The submission was made pursuant to Regulation 30 read with Schedule III, Part A, Para A, Clause 15(b) of the SEBI (LODR) Regulations, 2015. Jatin Jain, Company Secretary & Compliance Officer of Fairchem Organics Limited, signed the communication addressed to the exchanges. The company has provided a direct link to the audio file on its investor relations website for public access.

Key Details

Detail Information
Event Earnings Call Audio Recording
Date Held July 28, 2026
Time 4:00 p.m. onwards
Period Covered Quarter Ended June 30, 2026 (Q4FY26)
Regulatory Reference Regulation 30, Schedule III, Part A, Para A, Clause 15(b) of SEBI (LODR) Regulations, 2015
Submission Date July 28, 2026

Regulatory Compliance

Fairchem Organics Limited is listed on both the National Stock Exchange of India Limited (NSE symbol: FAIRCHEMOR) and BSE Limited (BSE Scrip Code: 543252). The company's registered office is located at 253/P and 312, Village – Chekhala, Sanand – Kadi Highway, Taluka : Sanand, Dist.: Ahmedabad – 382 115, Gujarat, India. The submission confirms the company's adherence to disclosure norms mandated by the Securities and Exchange Board of India (SEBI).

What the Numbers Show

While this filing pertains to the availability of the earnings call recording rather than the financial figures themselves, it marks the conclusion of the immediate reporting cycle for Q4FY26. Investors are directed to the audio recording for detailed insights into revenue trends, profit margins, and operational updates for the quarter ended June 30, 2026. The availability of the recording allows for independent verification of management's statements regarding the company's financial health and strategic direction.

Historical Stock Returns for Fairchem Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-2.00%+18.19%+28.94%+29.50%-7.14%-50.57%

How will the Q4FY26 revenue and margin trends discussed in the earnings call influence Fairchem Organics' guidance for the upcoming fiscal year?

What specific operational strategies did management outline to address potential volatility in raw material costs or demand for specialty chemicals in FY27?

Are there any announced capital expenditure plans or new product launches mentioned during the call that could drive long-term growth for the company?

Fairchem Organics shareholders approve dividend, director re-appointments

2 min read     Updated on 28 Jul 2026, 12:43 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Fairchem Organics Limited concluded its 7th AGM on July 27, 2026, with shareholders approving a final dividend of Re. 1.00 per share and the re-appointment of key board members. The scrutinizer’s report confirmed that all resolutions, including the adoption of FY26 financials and cost auditor remuneration, were passed with significant majority support.

powered bylight_fuzz_icon
46697643

*this image is generated using AI for illustrative purposes only.

Fairchem Organics Limited shareholders overwhelmingly approved a final dividend of Re. 1.00 per equity share and the re-appointment of key board members at its 7th Annual General Meeting (AGM) held on July 27, 2026. The meeting, conducted via Video Conferencing/Other Audio Visual Means (OAVM), saw high participation with 49 shareholders casting votes on all resolutions, reflecting strong engagement from the investor base.

The scrutinizer’s report, submitted by Uday Dave of Parikh Dave & Associates, confirmed that all six resolutions placed before the members were passed. The dividend declaration for the financial year ended March 31, 2026, received near-unanimous support, while the re-appointment of Managing Director Nahoosh Jariwala and Independent Director Sudhin Choksey also secured overwhelming assent. The results were filed with the stock exchanges pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Voting Results Breakdown

The remote e-voting window was open from July 22 to July 26, 2026, followed by e-voting during the AGM. The consolidated results for each resolution are detailed below:

Resolution Particulars Assent Votes Dissent Votes Abstain Votes Support %
1 Adoption of Financial Statements (FY26) 89,48,980 5 0 100.00%
2 Final Dividend of Re. 1.00 per share 89,48,880 5 100 100.00%
3 Re-appointment of Sumit Maheshwari 86,73,829 2,75,056 100 96.93%
4 Re-appointment of Nahoosh Jariwala as MD 89,48,829 56 100 100.00%
5 Re-appointment of Sudhin Choksey as Ind. Dir. 86,73,783 2,75,102 100 96.92%
6 Ratification of Cost Auditors' Remuneration 89,48,829 56 100 100.00%

Key Appointments and Governance

The special resolutions included the re-appointment of Nahoosh Jariwala as Managing Director for a further period of three years, effective August 13, 2026, to August 12, 2029. This resolution received nearly unanimous support, with only 56 dissenting votes out of over 89 lakh total votes cast. Similarly, the re-appointment of Sudhin Choksey as an Independent Director for a second term of five years, effective February 11, 2027, was approved with 96.92% support.

Sumit Maheshwari, who retires by rotation, was re-appointed as a Director under an ordinary resolution. While this resolution passed with 96.93% support, it recorded higher dissent compared to other items, with 2,75,056 votes cast against it. The adoption of the audited financial statements for FY26 and the ratification of remuneration payable to Cost Auditors for FY27 also received full support from the voting shareholders.

What the Numbers Show

The voting pattern indicates strong shareholder confidence in the company’s leadership and financial reporting. The negligible dissent on the dividend declaration and the MD’s re-appointment suggests alignment between management strategy and shareholder interests. The slightly higher dissent on the re-appointments of Sumit Maheshwari and Sudhin Choksey, though still resulting in approval, may reflect active engagement from a segment of the investor base regarding board composition, although the overall outcome remains decisive in favor of management proposals.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0DNW01011/54daa2cd-4802-4eb1-8e74-6ba05ee1f1ac.pdf

Historical Stock Returns for Fairchem Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-2.00%+18.19%+28.94%+29.50%-7.14%-50.57%

How might the re-appointment of Nahoosh Jariwala as MD influence Fairchem Organics' strategic expansion plans for the 2026-2029 period?

What operational or governance factors could explain the higher dissent votes for Sumit Maheshwari and Sudhin Choksey compared to other board members?

Given the modest final dividend of Re. 1.00, will management prioritize capital expenditure or debt reduction in the upcoming fiscal year?

More News on Fairchem Organics

1 Year Returns:-7.14%